View of Monoclonal Antibody Therapy in Early Alzheimer’s disease: a Review of Lecanemab and Aducanumab

Return to Article Details Monoclonal Antibody Therapy in Early Alzheimer’s disease: a Review of Lecanemab and Aducanumab Download Download PDF